These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10738697)

  • 21. Role of alum in improving the immunogenicity of biodegradable polymer particle entrapped antigens.
    Kanchan V; Katare YK; Panda AK
    Eur J Pharm Sci; 2009 Aug; 38(1):18-28. PubMed ID: 19467323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
    Maa YF; Zhao L; Payne LG; Chen D
    J Pharm Sci; 2003 Feb; 92(2):319-32. PubMed ID: 12532382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable microspheres as a vaccine delivery system.
    Eldridge JH; Staas JK; Meulbroek JA; McGhee JR; Tice TR; Gilley RM
    Mol Immunol; 1991 Mar; 28(3):287-94. PubMed ID: 2017198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.
    Velashjerdi Farahani S; Reza Aghasadeghi M; Memarnejadian A; Faezi S; Shahosseini Z; Mahdavi M
    Pathog Glob Health; 2016 Mar; 110(2):39-47. PubMed ID: 26403975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes.
    Shukla A; Singh B; Katare OP
    Br J Pharmacol; 2011 Sep; 164(2b):820-7. PubMed ID: 21506959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles.
    Katare YK; Panda AK
    Eur J Pharm Sci; 2006 Jun; 28(3):179-88. PubMed ID: 16517132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antibody response in the bovine mammary gland is influenced by the adjuvant and the site of subcutaneous vaccination.
    Boerhout EM; Koets AP; Mols-Vorstermans TGT; Nuijten PJM; Hoeijmakers MJH; Rutten VPMG; Bijlsma JJE
    Vet Res; 2018 Mar; 49(1):25. PubMed ID: 29490692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines.
    Tritama E; Riani C; Rudiansyah I; Hidayat A; Kharisnaeni SA; Retnoningrum DS
    Hum Vaccin Immunother; 2018 Jun; 14(6):1524-1529. PubMed ID: 29359991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS; Vyas SP
    Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced immune response against pertussis toxoid by IgA-loaded chitosan-dextran sulfate nanoparticles.
    Sharma S; Mukkur TK; Benson HA; Chen Y
    J Pharm Sci; 2012 Jan; 101(1):233-44. PubMed ID: 21953499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle-based immunopotentiation via tetanus toxoid-loaded gelatin and aminated gelatin nanoparticles.
    Sudheesh MS; Vyas SP; Kohli DV
    Drug Deliv; 2011 Jul; 18(5):320-30. PubMed ID: 21351824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The partially degraded lipopolysaccharide of Burkholderia cepacia and ornithine-containing lipids derived from some Gram-negative bacteria are useful complex lipid adjuvants.
    Kawai Y; Watanabe M; Matsuura M; Nishijima M; Kawahara K
    FEMS Immunol Med Microbiol; 2002 Nov; 34(3):173-9. PubMed ID: 12423768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential Immune Responses in Mice Immunized with Recombinant Neutralizing Epitope Protein of Hepatitis E Virus Formulated with Liposome and Alum Adjuvants.
    Joshi SS; Arankalle VA
    Viral Immunol; 2016; 29(6):350-60. PubMed ID: 27285290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
    Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
    Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern.
    Johansen P; Corradin G; Merkle HP; Gander B
    J Control Release; 1998 Dec; 56(1-3):209-17. PubMed ID: 9801444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soybean agglutinin coated PLA particles entrapping candidate vaccines induces enhanced primary and sustained secondary antibody response from single point immunization.
    Gupta RK; Goswami DG; Singh RR; Surolia A; Panda AK
    Eur J Pharm Sci; 2012 Feb; 45(3):282-95. PubMed ID: 22155747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres.
    Gutierro I; Hernández RM; Igartua M; Gascón AR; Pedraz JL
    Vaccine; 2002 Nov; 21(1-2):67-77. PubMed ID: 12443664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of immune response from polymer-entrapped antigen: toward development of single dose tetanus toxoid vaccine.
    Katare YK; Panda AK; Lalwani K; Haque IU; Ali MM
    Drug Deliv; 2003; 10(4):231-8. PubMed ID: 14612338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen.
    Kersten GF; Donders D; Akkermans A; Beuvery EC
    Vaccine; 1996 Dec; 14(17-18):1627-32. PubMed ID: 9032891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.